Saved report copy
Recorded
Medicare’s $50 obesity drug pilot gains traction at major pharmacies
NPR reports that CVS and Walgreens have each filled roughly 100,000 prescriptions through Medicare’s Bridge pilot, while Walmart says activity is growing across more than 5,000 pharmacies and Sam’s Club locations. The program offers eligible beneficiaries obesity drugs for $50 a month, though people with Type 2 diabetes or sleep apnea are excluded because Medicare Part D may already cover treatment for those conditions. Medicare estimated about 4 million people could qualify, while CMS said 250,000 beneficiaries had signed up, although it was unclear how many had obtained required authorization.